CTRI/2017/09/009783已完成2 期
Efficacy of Itrifal-e-Sagheer in Dyslipidaemia: A randomised single blind controlled trial.
Sazid Alam0 个研究点目标入组 30 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Diagnosed patients of dyslipidaemia
- •2.Patients of either gender in age group of 20-60 years
排除标准
- •1.Other systemic disorders like DM, liver failure, kidney failure, etc.
- •2.Pregnant and lactating women.
研究者
相似试验
尚未招募
2 期
Effect of Unani drug on DyslipidemiaCTRI/2020/09/027924ational Institute of Unani Medicine
已完成
2 期
Treatment of Hyperlipedemia with Unani formulatioCTRI/2018/05/013864Central Council for Research in Unani Medicine60
招募中
Unknown
A Clinical study in patients with dyslipidemia to determine the actual status of the percentage of patients achieving the target values for the management of LDL-Cholesterol specified in the Japan Atherosclerosis Society Guidelines for the Prevention of Atherosclerotic Cardiovascular Diseases (2022 edition)DyslipidemiaJPRN-UMIN000051501TOKYO CENTER CLINIC180
已完成
不适用
A Clinical study in patients with dyslipidemia to determine the status of recognition and the percentage of patients achieving the target values for the management of each lipid parameter specified in the Japan Atherosclerosis Society Guidelines for the Prevention of Atherosclerotic Cardiovascular Diseases (2022 edition), and to follow-up the achievement of the target values by subsequent treatment approaches.DyslipidemiaJPRN-UMIN000046687Medical Corporation Chiseikai Tokyo Center Clinic350
已完成
不适用
Investigation for the effect of anti-dyslipidemic drugs on serum level of trans-fatty acidsdyslipidemiaJPRN-UMIN000026984Kobe University Graduate School of Medicine40